Encouraging results from a pilot study of thiamine in CMT

Thiamine, or vitamin B1, is important for nerve cell function. Administered as a dietary supplement, it is thought to have beneficial effects in a number of neurological diseases.

Russian researchers have studied its therapeutic value in Charcot-Marie-Tooth disease.

  • A pilot study involving 15 patients with CMT 1A showed an improvement in grip strength thanks to daily intake of a high dose of thiamine (100 mg).
  • The mechanism of action of thiamine in CMT remains to be determined, but analyses did not show any thiamine deficiency in these patients.

 

Pharmacological Doses of Thiamine Benefit Patients with the Charcot-Marie-Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes. Artiukhov AV, Solovjeva ON, Balashova NV et al. Biochemistry (Mosc). 2024 Jul